首页> 外文OA文献 >Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin

【2h】

Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin

机译：用二甲双胍治疗2型糖尿病患者使用磺酰脲A1C水平的血红蛋白A1C水平与二甲双胍治疗的2型糖尿病患者的促进剂

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Rohit Vashisht; Kenneth Jung; Alejandro Schuler; Juan M. Banda; Rae Woong Park; Sanghyung Jin; Li Li; Joel T. Dudley; Kipp W. Johnson; Mark M. Shervey; Hua Xu; Yonghui Wu; Karthik Natrajan; George Hripcsak; Peng Jin; Mui Van Zandt; Anthony Reckard; Christian G. Reich; James Weaver; Martijn J. Schuemie; Patrick B. Ryan; Alison Callahan; Nigam H. Shah;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Combination therapy of metformin plus dipeptidyl peptidase-4 inhibitor versus metformin plus sulfonylurea and their association with a decreased risk of cardiovascular disease in type 2 diabetes mellitus patients [J] . Wang Fei, He Yuan, Zhang Rong, Medicine. . 2017,第36期

机译：二甲双胍加二肽基肽酶-4抑制剂与二甲双胍加磺脲类药物的联合治疗及其与2型糖尿病患者降低心血管疾病风险的关系
2. Combination Therapy with a Dipeptidyl Peptidase-4 Inhibitor, Sulfonylurea, and Metformin Markedly Improves HbA1c Levels in Japanese Patients with Type 2 Diabetes Mellitus [J] . Koichi Hirao, Hajime Maeda, Shin-ichiro Shirabe, Japanese Clinical Medicine . 2012,第3期

机译：与二肽基肽酶-4抑制剂，磺酰脲和二甲双胍联合治疗显着改善日本2型糖尿病患者的HbA1c水平。
3. Serum level of soluble CD26/dipeptidyl peptidase-4 (DPP-4) predicts the response to sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes controlled inadequately by metformin and/or sulfonylurea [J] . AsoY., OzekiN., TerasawaT., Translational research: the journal of laboratory and clinical medicine . 2012,第1期

机译：血清CD26 /二肽基肽酶-4（DPP-4）的水平预测了二甲双胍和/或磺脲类药物控制不佳的2型糖尿病患者对西他列汀（DPP-4抑制剂）的反应
4. Fragment-Based Drug Design to Discover Novel Inhibitor of Dipeptidyl Peptidase-4 (DPP-4) as a Potential Drug for Type 2 Diabetes Therapy [C] . Eka Gunarti Ningsih, Muhammad Fauzi Hidayat, Usman Sumo Friend Tambunan International work-conference on bioinformatics and biomedical engineering . 2019

机译：基于片段的药物设计，发现二肽基肽酶-4（DPP-4）的新型抑制剂作为2型糖尿病治疗的潜在药物
5. Using MyPlate Nutrition Education to Improve Glycated Hemoglobin (A1c) Levels in African American Adults with Type 2 Diabetes [D] . Ogbonnia, Ijeoma Valerie. 2021

机译：使用MyPlate Nutrition教育改善非洲裔美国成年人患有2型糖尿病的糖化血红蛋白（A1C）水平
6. Evaluation of Dipeptidyl Peptidase-4 Inhibitors versus Thiazolidinediones or Insulin in Patients with Type 2 Diabetes Uncontrolled with Metformin and a Sulfonylurea in a Real-World Setting [O] . Natalie Aboubechara, Vittoria Marie Ledesma, Fang Niu, 2020

机译：二肽基肽酶-4抑制剂对患者对二唑烷二氧化铂或胰岛素的评价其2型糖尿病患者在真实世界的环境中与二甲双胍和磺酰脲类作出不受控制的
7. Combination therapy of metformin plus dipeptidyl peptidase-4 inhibitor versus metformin plus sulfonylurea and their association with a decreased risk of cardiovascular disease in type 2 diabetes mellitus patients [O] . Fei Wang, Yuan He, Rong Zhang, 2017

机译：二甲双胍加二肽肽肽酶-4抑制剂与二甲双胍加磺酰脲类的联合治疗及其与2型糖尿病患者的心血管疾病风险降低的关联

Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin

著录项

引文网络

相似文献

相关主题

期刊订阅